Roivant Sciences (ROIV) CFO uses 2,129 shares to cover RSU taxes

Rhea-AI Filing Summary

Roivant Sciences Ltd. CFO Richard Pulik reported a routine share disposition tied to equity compensation. On the RSU vesting date, 2,129 common shares at $31.43 per share were withheld by the company to satisfy tax withholding obligations through a net settlement of previously granted RSUs. Following this tax-related transfer, Pulik directly holds 276,420 common shares of Roivant Sciences Ltd.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pulik Richard

Role CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares	2,129	$31.43	$67K

Holdings After Transaction: Common Shares — 276,420 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares used for tax withholding: 2,129 shares Price per share: $31.43/share Shares held after transaction: 276,420 shares

3 metrics

Shares used for tax withholding 2,129 shares Common shares net settled to cover RSU tax obligations

Price per share $31.43/share Value used for the 2,129-share tax-withholding disposition

Shares held after transaction 276,420 shares Roivant Sciences common shares directly held by CFO after Form 4 transaction

Key Terms

RSUs, net settlement, tax withholding obligations

3 terms

RSUs financial

"RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

net settlement financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

tax withholding obligations financial

"in order to satisfy applicable tax withholding obligations in connection with the vesting"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pulik Richard

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	06/20/2026		F		2,129(1)	D	$31.43	276,420	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Remarks:

	By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Roivant Sciences (ROIV) report for its CFO?

Roivant Sciences reported that CFO Richard Pulik had 2,129 common shares withheld to cover tax obligations on vested RSUs. The disposition was a net settlement, not an open-market purchase or sale of shares.

How many Roivant Sciences shares were involved in Richard Pulik’s tax withholding?

A total of 2,129 Roivant Sciences common shares were used to satisfy tax withholding obligations. The shares were net settled in connection with the vesting and settlement of previously granted restricted stock units.

Does the Roivant Sciences CFO still hold a significant share position after this Form 4?

After the tax-withholding disposition, CFO Richard Pulik directly holds 276,420 Roivant Sciences common shares. This filing shows only a small portion of his overall reported holdings was used to meet tax obligations on RSU vesting.

Was the Roivant Sciences (ROIV) CFO’s Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. The 2,129 shares represent a net settlement by Roivant Sciences to satisfy applicable tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units.

What does “net settlement” mean in the Roivant Sciences CFO’s Form 4 filing?

In this context, net settlement means Roivant Sciences withheld 2,129 shares from vested RSUs to cover tax withholding obligations. Instead of paying taxes in cash, a portion of the shares was automatically used to satisfy the tax liability.